Decrease of M2 macrophages within the tumor by Akt inhibitor, even when combined with RT + αPD-L1/αCTLA-4, was further supported by a reduction in CD163 expression in immunohistochemistry (IHC) staining (Figures 5D and 5E). Here, CD163 is linked to neoplasm.